Cancer Vaccine Development Program Collaborations
نویسندگان
چکیده
منابع مشابه
Creative Research & Development Collaborations
Around the world there are many examples of how universities and industry work together to create new knowledge and new economic value. Motivating creative, smart people to work together can be one of the hardest aspects of such endeavours, especially where various arrangements and agreements need to take the commercial interests of industry into account as well as the highly aspirational inter...
متن کاملStrategies for Cancer Vaccine Development
Treating cancer with vaccines has been a challenging field of investigation since the 1950s. Over the years, the lack of effective active immunotherapies has led to the development of numerous novel strategies. However, the use of therapeutic cancer vaccines may be on the verge of becoming an effective modality. Recent phase II/III clinical trials have achieved hopeful results in terms of overa...
متن کاملAPIC's Strategic Partner Program and Productive Collaborations.
A foundational goal of the Strategic Partner Program, APIC’s platform for engagement with industry at the leadership and strategic level, is to promote balanced collaboration among healthcare professionals, industry, academia, and the Association. Central to promoting such collaboration are: one, making more visible the productive collaborations that already exist as a result of interactions be...
متن کاملVaxign: The First Web-Based Vaccine Design Program for Reverse Vaccinology and Applications for Vaccine Development
Vaxign is the first web-based vaccine design system that predicts vaccine targets based on genome sequences using the strategy of reverse vaccinology. Predicted features in the Vaxign pipeline include protein subcellular location, transmembrane helices, adhesin probability, conservation to human and/or mouse proteins, sequence exclusion from genome(s) of nonpathogenic strain(s), and epitope bin...
متن کاملMulti - stakeholder Collaborations & Biomarker Development and Implementation
The rise of genomic technologies and increasing interest in personalized medicine have triggered a renewed focus on the role of biomarkers in drug development and clinical care. While many stakeholders, including industry, regulatory agencies, patients, academia, and payers, are involved in biomarker development and use, these stakeholders reside in functional siloes that lead to fragmented out...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Military Medicine
سال: 2010
ISSN: 0026-4075,1930-613X
DOI: 10.7205/milmed-d-10-00171